Skip to main content

Study M698

Study name

Guo JJ 2020

Title

Proteomics-based screening of the target proteins associated with antidepressant-like effect and mechanism of Saikosaponin A

Overall design

The aim of this study was to explore the anti-depression effect of Saikosaponin A and screen the target proteins regulated by Saikosaponin A in a rat model of chronic unpredictable mild stress (CUMS)-induced depression. Sprague-Dawley rats were divided into the following 3 groups (n = 15 in each group): (1) control group, (2) CUMS group, and (3) CUMS + Saikosaponin A group (stressor plus Saikosaponin A treatment at the dose of 50 mg/kg). The CUMS stress procedure lasted for 8 weeks, and drugs were administered via intragastric once per day during the last 4 weeks. 5-Hydroxytryptamine, norepinephrine and dopamine levels in the hippocampus were measured using HPLC-MS (n = 6 per group).

Study Type

Type1;

Type2;

Data available

Unavailable

Organism

Rat; Sprague-Dawley rat;

Categories of depression

Animal model; Chronic mild stress model; Chronic mild stress model;

Criteria for depression

Sucrose preference test

Sample size

18

Tissue

Central; Brain; Hippocampus;

Platform

MS-based; LC-MS: Agilent 1200 series HPLC system (Agilent, USA) with mass spectrometer (Agilent, 6410B, USA);

PMID

31762213

DOI

10.1111/jcmm.14695

Citation

Guo J, Zhang F, Gao J, et al. Proteomics-based screening of the target proteins associated with antidepressant-like effect and mechanism of Saikosaponin A. J Cell Mol Med. 2020;24(1):174-188.

Metabolite

Serotonin;

Dopamine;